Single Institutional Experience Using Radiation Therapy in the Treatment of Neuroendocrine Tumor Primary and Metastatic Lesions
Kaitlin Qualls(Mayo Clinic), Krishan R. Jethwa(Mayo Clinic), J. Schoffner, Christopher L. Hallemeier(Mayo Clinic in Arizona), Michael G. Haddock(Mayo Clinic in Arizona), Kenneth W. Merrell(Mayo Clinic), Christopher Dodoo(Mayo Clinic in Arizona), Þorvarður R. Hálfdánarson(Mayo Clinic), H.J. Gunn(Mayo Clinic in Arizona)
International Journal of Radiation Oncology*Biology*Physics
September 29, 2023
Cited by 1
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
|Endocrine Related Cancer|2008|374